References
- Davies HD, McGeer A, Schwartz: B, et al, for the Ontario Group A Streptococcal Study Group. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996; 335(8): 547–54
- Holm SE, Norrby A, Bergholm AM, et al. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988–1989. J Infect Dis 1992; 166(1): 31–7
- Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321(1); 1–7
- Hauser AR, Stevens DL, Kaplan EL, et al. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock—tike syndrome. J Clin Microbiol 1991; 29(8); 1562–7
- Hsueh PR, Wu JJ, Tsai PJ, et al. Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin Infect Dis 1998; 26(3): 584–9
- Talkington DF, Schwartz B, Black CM, et al. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 1993; 61(8): 3369–74
References
- Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993; 269(3): 390–1
- Davies HD, McGeer A, Schwartz B, et al, for the Ontario Group A Streptococcal Study Group. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996; 335(8): 547–54
- Katz AR, Morens DM. Severe streptococcal infections in historical perspective. Clin Infect Dis 1992; 14(1): 298–307
- Cone LA, Woodard DR, Schlievert PM, et al. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 1987; 317(3): 146–9
- Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321(1): 1–7
- Hoge CW, Schwartz B, Talkington DF, et al. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: a retrospective population-based study. JAMA 1993; 269 (3): 384–9 [Erratum, JAMA 1993; 269(13): 1638]
- Kaul R, McGeer A, Low DE, et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med 1997; 103(1): 18–24
- Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995; 1(3): 69–78
- Auerbach SB, Schwartz B, Williams D, et al. Outbreak of invasive group A streptococcal infections in a nursing home: lessons on prevention and control. Arch Intern Med 1992; 152(5): 1017–22
- Gamba MA, Martinelli M, Schaad HJ, et al. Familial transmission of a serious disease-producing group A streptococcus clone: case reports and review. Clin Infect Dis 1997; 24(6): 1118–21
- Demers B, Simor AE, Vellend H, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987–1991. Clin Infect Dis 1993; 16(6): 792–800; discussion 801–2
- Brogan TV, Nizet V, Waldhausen JH, et al. Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J 1995; 14(7): 588–94
- Eagle H. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 1952; 13(Oct): 389–99
- Stevens DL, Gibbons AE, Bergstrom R, et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988; 158(1): 23–8
- Stevens DL, Yan S, Bryant AE. Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis 1993; 167(6): 1401–5
- Perez CM, Kubak BM, Cryer HG, et al. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review. Am J Med 1997; 102(1): 111–3
- Smith RJ, Berk SL. Necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. South Med J 1991; 84(6): 785–7
- Stevens DL. Could nonsteroidal anti-inflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 1995; 21(4): 977–80